OncoMatch/Clinical Trials/NCT05813626
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Is NCT05813626 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies Toripalimab for nasopharyngeal carcinoma.
Treatment: Toripalimab — Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally advanced nasopharyngeal carcinoma
Check if I qualifyExtracted eligibility criteria
Cancer type
Head and Neck Squamous Cell Carcinoma
Performance status
ECOG 0–1(Restricted strenuous activity)
Lab requirements
Blood counts
white blood cell count > 4×10^9/L, hemoglobin > 90g/L, platelet count > 100×10^9/L
Kidney function
creatinine clearance rate ≥ 60 ml/min
Liver function
total bilirubin ≤ 1.5 × ULN; alanine transaminase and aspartate transaminase ≤ 2.5 × ULN; alkaline phosphatase ≤ 2.5 × ULN
Cardiac function
normal myocardial enzymes and ECG results; for patients >50 years with smoking history, normal lung function required; patients with abnormal ECG and/or vascular disease history need normal myocardial function and color Doppler ultrasound
Normal bone marrow function: white blood cell count > 4×10^9/L, hemoglobin > 90g/L, platelet count > 100×10^9/L; Normal values of thyroid function, amylase and lipase examination, pituitary function, inflammation and infection indicators, myocardial enzymes, and ECG results. For patients older than 50 years with a smoking history, normal lung function are required. Patients with abnormal ECG and/or a history of vascular disease (but not meeting the exclusion criteria listed in the exclusion criteria 7) need further testing and require normal results of myocardial function and color Doppler ultrasound. Normal liver and kidney function: total bilirubin ≤ 1.5 × ULN; alanine transaminase and aspartate transaminase ≤ 2.5 × ULN; alkaline phosphatase ≤ 2.5 × ULN; creatinine clearance rate ≥ 60 ml/min;
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify